JAK Inhibitor and Crohn's Disease.

Biomedicines · 2025 · PMC12189809 · PMID 40564044

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the induction treatment phase of filgotinib, although it can significantly improve the clinical symptoms of CD, the endoscopic remission rate did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.